Magic mushrooms trial aims to unlock fluency for people who stutter
NCT ID NCT07296328
Summary
This early-stage study is testing whether a single dose of psilocybin, the active compound in 'magic mushrooms,' can help adults who stutter. Researchers will measure changes in speech fluency, the physical struggle of stuttering, and brain activity in 25 participants. The goal is to see if this approach is safe and shows enough promise to justify larger future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STUTTERING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NYU Langone Health
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.